Trade Minister Don Farrell has opened up on how the Albanese government will argue to the Trump Administration why Australia should be exempt from the doubling of steel and aluminium tariffs.

A Global Trade Research Initiative report warns that U.S. President Trump's decision to double tariffs on steel and aluminium imports, effective June 4, 2025, will significantly impact India's metal ...

During a rally in West Mifflin, Pennsylvania, US President Donald Trump revealed his intention to raise import duties on steel and aluminium products to 50 per cent, doubling the existing 25 per cent ...

Benkam participated in Aluminium USA 2025 in Nashville, presenting its latest aluminum extrusion solutions for construction and industrial applications. The company held strategic meetings with ...

President Donald Trump has announced the US will double its current tariff rate on steel and aluminium imports from 25% to 50%, starting on Wednesday.

So, the next best thing you can do is know how to spot a fake profile on Facebook, Instagram, Tinder, or any other platform that scammers like to prey on. PeopleWin explains how to spot fake ...

Chef Phila Lorn was not necessarily aiming for “quote-unquote authentic” Cambodian food when he opened Mawn in his native Philadelphia two years ago. So when he approached some Cambodian teen ...

Despite his slender build, Benjamin Rautiainen offers a lot to like about his game, especially on the offensive end. Capable of playing both center and wing, he has a high hockey IQ and reads the ...

Here is the detailed job profile for IBPS PO. Assisting customers in resolving their queries at the branch level. Overseeing and managing day-to-day operations and activities of the branch. Handling ...

Four top lawyers at Paul Weiss said Friday they would depart from their roles as partners at the law firm to form their own practice. “We were disappointed not to be able to tell each of you ...

Writing to investors early on Friday, analysts at William Blair said Merus’ latest data drop continues to “support the best-in-disease profile of petosemtamab” ahead of Phase III data expected next ...